Researcher
Daniel Engelbert Blockmans
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory for Clinical Infectious and Inflammatory Disorders (Division)
Member
From1 Oct 1999 → Today
Projects
1 - 3 of 3
- Unmet medical needs in systemic inflammatory syndromes and vasculitis. Focus on giant cell arteritis and polymyalgia rheumatica’From1 Oct 2021 → TodayFunding: BOF - doctoral mandates
- Mass spectrometry-based autoantibody tests for specific diagnosis of autoimmune diseasesFrom1 Oct 2020 → 30 Sep 2022Funding: IOF - technology validation in lab
- Contemporary diagnostic challenges in general internal medicine: focus on updating the approach to fever and inflammation of unknown originFrom1 Oct 2019 → 7 Sep 2023Funding: BOF - doctoral mandates
Publications
31 - 40 of 216
- Incidence, prevalence and long-term progression of Goh algorithm rated interstitial lung disease in systemic sclerosis in two independent cohorts in flanders: A retrospective cohort study(2021)
Authors: Daniel Engelbert Blockmans, Rene Westhovens, Wim Wuyts, Ellen De Langhe
Pages: 969 - 976 - Case Report: VEXAS Syndrome: From Mild Symptoms to Life-Threatening Macrophage Activation Syndrome (vol 12, 678927, 2021)(2021)
Authors: Frederik Staels, Nancy Boeckx, Mariëlle Beckers, Barbara Neerinckx, Daniel Engelbert Blockmans, Steven Vanderschueren
- Titre-specific positive predictive value of antinuclear antibody patterns(2021)
Authors: Jean-Baptiste Vulsteke, Lieve Van Hoovels, Steven Vanderschueren, Rene Westhovens, Daniel Engelbert Blockmans, Ellen De Langhe, Xavier Bossuyt
- Panniculitis as the first clinical manifestation of myeloperoxidase-positive perinuclear antineutrophil cytoplasmic antibody-associated vasculitis: comment on the article by Micheletti et al(2021)
Authors: Dries Deleersnijder, Petra De Haes, Daniel Engelbert Blockmans
Pages: 1088 - 1089 - Long-term effect of tocilizumab in patients with giant cell arteritis: open-label extension phase of the Giant Cell Arteritis Actemra (GiACTA) trial.(2021)
Authors: Daniel Engelbert Blockmans
Pages: e328 - e336 - How specific are elevated IgG4 levels for IgG4-related disease?(2021)
Authors: Steven Vanderschueren, Xavier Bossuyt, Daniel Engelbert Blockmans
Pages: 115 - 118 - Case Report: VEXAS Syndrome: From Mild Symptoms to Life-Threatening Macrophage Activation Syndrome(2021)
Authors: Frederik Staels, Nancy Boeckx, Mariëlle Beckers, Barbara Neerinckx, Stephanie Humblet-Baron, Daniel Engelbert Blockmans, Steven Vanderschueren, Rik Schrijvers
- Detection of multiple myositis-specific autoantibodies in unique patients(2021)
Authors: Jean-Baptiste Vulsteke, Xavier Bossuyt, Kristl Claeys, Koen Poesen, Daniel Engelbert Blockmans, Petra De Haes, Ellen De Langhe
Pages: 486 - 494 - Formerly undetected giant cell arteritis revealed at hysterectomy(2021)
Authors: Koen Van Laere, Anne-Sophie Van Rompuy, Daniel Engelbert Blockmans
Pages: E141 - E142 - Systemic autoinflammatory disease in adults(2021)
Authors: Frederik Staels, Rik Schrijvers, Isabelle Meyts, Stephanie Humblet-Baron, Ellen De Langhe, Carine Wouters, Daniel Engelbert Blockmans, Steven Vanderschueren